These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34208502)

  • 1. Repurposing Drugs to Treat Heart and Brain Illness.
    Cantrell MS; Soto-Avellaneda A; Wall JD; Ajeti AD; Morrison BE; Warner LR; McDougal OM
    Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34208502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
    Lanza V; Milardi D; Di Natale G; Pappalardo G
    Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repurposing for cardiovascular diseases: New targets and indications for probenecid.
    Onódi Z; Koch S; Rubinstein J; Ferdinandy P; Varga ZV
    Br J Pharmacol; 2023 Mar; 180(6):685-700. PubMed ID: 36484549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposed drug candidates for antituberculosis therapy.
    An Q; Li C; Chen Y; Deng Y; Yang T; Luo Y
    Eur J Med Chem; 2020 Apr; 192():112175. PubMed ID: 32126450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections.
    Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
    Curr Med Chem; 2021; 28(15):2887-2942. PubMed ID: 32787752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Repurposing: Insights into Current Advances and Future Applications.
    Bhatia T; Sharma S
    Curr Med Chem; 2023 Nov; ():. PubMed ID: 37946344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease.
    Johnston TH; Lacoste AMB; Visanji NP; Lang AE; Fox SH; Brotchie JM
    Neuropharmacology; 2019 Mar; 147():11-27. PubMed ID: 29907424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing old drugs to fight multidrug resistant cancers.
    Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
    Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
    Mohammad Sadeghi H; Adeli I; Mousavi T; Daniali M; Nikfar S; Abdollahi M
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repurposing: A multi targetted approach to treat cardiac disease from existing classical drugs to modern drug discovery.
    Tripathi S; Rani K; Raj VS; Ambasta RK
    Prog Mol Biol Transl Sci; 2024; 207():151-192. PubMed ID: 38942536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'RE:fine drugs': an interactive dashboard to access drug repurposing opportunities.
    Moosavinasab S; Patterson J; Strouse R; Rastegar-Mojarad M; Regan K; Payne PR; Huang Y; Lin SM
    Database (Oxford); 2016; 2016():. PubMed ID: 27189611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.
    Stenvang J; Kümler I; Nygård SB; Smith DH; Nielsen D; Brünner N; Moreira JM
    Front Oncol; 2013 Dec; 3():313. PubMed ID: 24400218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues.
    Kakoti BB; Bezbaruah R; Ahmed N
    Front Pharmacol; 2022; 13():1007315. PubMed ID: 36263141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.
    Hernandez JJ; Pryszlak M; Smith L; Yanchus C; Kurji N; Shahani VM; Molinski SV
    Front Oncol; 2017; 7():273. PubMed ID: 29184849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Repurposing: Claiming the Full Benefit from Drug Development.
    Kort E; Jovinge S
    Curr Cardiol Rep; 2021 May; 23(6):62. PubMed ID: 33961142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection.
    Sahoo BM; Ravi Kumar BVV; Sruti J; Mahapatra MK; Banik BK; Borah P
    Front Mol Biosci; 2021; 8():628144. PubMed ID: 33718434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions.
    Polamreddy P; Gattu N
    Drug Discov Today; 2019 Mar; 24(3):789-795. PubMed ID: 30513339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repositioning for orphan diseases.
    Sardana D; Zhu C; Zhang M; Gudivada RC; Yang L; Jegga AG
    Brief Bioinform; 2011 Jul; 12(4):346-56. PubMed ID: 21504985
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.